Campbell & Co Investment Adviser’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
24,840
-17,142
-41% -$794K 0.06% 499
2026
Q1
$1.84M Sell
41,982
-9,093
-18% -$415K 0.1% 308
2025
Q4
$2.26M Buy
51,075
+31,844
+166% +$1.37M 0.11% 291
2025
Q3
$812K Sell
19,231
-16,143
-46% -$651K 0.06% 508
2025
Q2
$1.3M Buy
35,374
+6,755
+24% +$251K 0.08% 393
2025
Q1
$1.09M Buy
28,619
+12,719
+80% +$473K 0.08% 399
2024
Q4
$602K Sell
15,900
-9,638
-38% -$385K 0.05% 589
2024
Q3
$1.04M Buy
25,538
+9,936
+64% +$376K 0.08% 424
2024
Q2
$534K Buy
15,602
+2,896
+23% +$91.2K 0.05% 628
2024
Q1
$402K Buy
+12,706
New +$386K 0.03% 796
2023
Q4
Sell
-6,943
Closed -$230K 1277
2023
Q3
$230K Buy
+6,943
New +$222K 0.03% 810
2023
Q2
Sell
-10,011
Closed -$274K 1053
2023
Q1
$274K Sell
10,011
-477
-5% -$13.3K 0.05% 637
2022
Q4
$293K Buy
+10,488
New +$316K 0.07% 561
2022
Q1
Sell
-7,224
Closed -$214K 843
2021
Q4
$214K Buy
+7,224
New +$211K 0.07% 511
2021
Q2
Sell
-7,424
Closed -$272K 664
2021
Q1
$272K Buy
+7,424
New +$273K 0.17% 259
2020
Q1
Sell
-7,752
Closed -$328K 363
2019
Q4
$328K Buy
+7,752
New +$328K 0.1% 383
2019
Q1
Sell
-14,940
Closed -$582K 582
2018
Q4
$582K Buy
+14,940
New +$518K 0.57% 15
2017
Q3
Sell
-9,491
Closed -$313K 426
2017
Q2
$313K Buy
+9,491
New +$314K 0.29% 128

Other funds holding OHI

Campbell & Co Investment Adviser's OHI Position: Q2 2026 in Review

Campbell & Co Investment Adviser reduced its Omega Healthcare (OHI) stake by 41% in Q2 2026, selling an estimated $794K and leaving 24,840 shares worth $1.18M. The position accounts for 0.06% of the portfolio, ranked #499.

Campbell & Co Investment Adviser first reported a position in OHI in Q2 2017 and has held it in 18 quarters since. The position peaked at $2.26M in Q4 2025. 407 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Campbell & Co Investment Adviser held 24,840 shares of Omega Healthcare worth $1.18M as of Q2 2026.
  • Campbell & Co Investment Adviser sold 17,142 Omega Healthcare shares in Q2 2026, an estimated $794K.
  • Omega Healthcare made up 0.06% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #499 holding.
  • Campbell & Co Investment Adviser first reported a position in Omega Healthcare in Q2 2017 and has held it in 18 quarters since.
  • Campbell & Co Investment Adviser's Omega Healthcare position peaked at $2.26M in Q4 2025.
  • 407 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.